Could Ocata Therapeutics Inc(OTCMKTS:OCAT), ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC), and Hooper Holmes, Inc.(NYSEMKT:HH)Dominate Their Respective Industries?

Posted by admin November 21, 2014 0 Comment 1104 views


New York, NY – GDP INSIDER  –  11/21/2014.

This article discusses three companies: Ocata Therapeutics Inc(OTCMKTS:OCAT), ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC), and Hooper Holmes, Inc.(NYSEMKT:HH)

Ocata Therapeutics Inc(OTCMKTS:OCAT) is a Massachusetts-based biotechnology company that develops and commercializes human pluripotent stem cell technology in the regenerative medicine field. The company is currently conducting clinical trials for the treatment of dry age-related macular degeneration. The stock has traded within a range of $4.95 to $12.73 over the past 52 weeks, yet finished yesterday’s trading at a closing price of $6.38 after a twelve cent loss. These figures suggest that investor confidence in Ocata Therapeutics is declining.

Will Ocata Therapeutics Break Out? View Our Free OCAT Analysis.

ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC) reported a net loss of $1.9 million, or $0.03 per share, for the third quarter on Nov. 10th, 2014. This figure is one-half of the company’s $3.8 million loss recorded during the third quarter of fiscal year 2013. The company, which has a market capitalization of $40.45 million, had a trading volume of 0.24 million yesterday. This figure, which is 0.20 million lower than its three month average trading volume of 0.44 million, suggests that investor interest in ImmunoCellular Therapeutics is falling.

Should You Invest In ImmunoCellular Therapeutics? Receive A Free IMUC Analysis.

Hooper Holmes, Inc.(NYSEMKT:HH) announced a consolidated revenue of $7.9 million for the third quarter of fiscal year 2014. This figure represents a $2.7 million increase from the figure recorded during the same period of the previous fiscal year. The stock has traded within a range of $0.44 to $0.83 over the past 52 weeks, yet finished yesterday’s trading at a closing price of $0.55 after a 3.1% loss. As with Ocata Therapeutics, it would appear that Hooper Holmes is on the decline.

Is Now the Time To Invest In Hooper Holmes? Take A Look At Our Free HH Analysis.

About HotStockGains

HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.

 


Write Your Comment